By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novavax, Inc. 

9920 Belward Campus Drive

Rockville  Maryland  20850  U.S.A.
Phone: 240-268-2000 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
Novavax (NVAX) Announces Exercise Of Over-Allotment Option To Purchase Additional Shares 2/8/2016 7:32:53 AM
Novavax (NVAX) Announces Closing Of $300 Million Offering Of Convertible Senior Notes Due 2023 2/1/2016 7:49:29 AM
Novavax (NVAX) Prices $300 Million Of Convertible Senior Notes Due 2023 1/26/2016 9:00:40 AM
Novavax (NVAX) Announces Proposed Offering Of $200 Million Of Convertible Senior Notes Due 2023 1/25/2016 7:30:23 AM
Novavax (NVAX) Appoints Jeffrey Stoddard, M.D., Vice President, Medical Affairs 1/8/2016 7:52:09 AM
Novavax (NVAX) To Present At The 34th Annual J.P. Morgan Healthcare Conference 1/7/2016 10:20:05 AM
Novavax (NVAX) Appoints Mark Twyman Vice President Marketing 12/22/2015 10:56:00 AM
Novavax (NVAX) Completes Enrollment Of Pivotal Phase III Trial Of The RSV F Vaccine In Older Adults 12/15/2015 7:55:27 AM
Novavax (NVAX) To Participate In The Guggenheim Securities 3rd Annual Boston Healthcare Conference 12/9/2015 7:39:06 AM
Novavax (NVAX) Initiates Global Pivotal Phase III Trial Of The RSV F Vaccine To Protect Infants Via Maternal Immunization 12/4/2015 7:36:13 AM
12345678910...
//-->